Cell Biology Newsroom

This spring, five faculty members with appointments in the Duke Department of Cell Biology have been awarded distinguished professorships. The new distinguished professors will be honored at the university’s annual distinguished professorship event on May 14.

The student awardees were selected for their publication record, influence on the research direction of their laboratory, and noteworthy and distinctive contributions to the scientific and academic community.

This exhibit offers a unique historical perspective from women in multiple fields, including cell biology’s Shelia Counce-Nicklas, PhD, and Brigid Hogan, PhD

The National Institutes of Health's proposal to cap reimbursement of facilities and administrative (F&A) costs on research grants at 15% would significantly slow or cease scientific and biomedical research at Duke and other research institutions. Here is an explanation of what F&A costs are and why they are such a critical piece of the research endeavor.

Cagla Eroglu, PhD, is the Duke Health Distinguished Professor of Cell Biology and a professor of neurobiology.

Duke University School of Medicine’s research symposium showcased how discovery science, AI, technology, and translation are driving progress on some of the biggest challenges in biomedical science.

Nicole Calakos, MD, PhD, is the Lincoln Financial Group Distinguished Professor of Neurobiology and specializes in synaptic physiology research and Parkinson’s disease and other movement disorders. She highlights the transformative impact of big data, AI, and cell modeling on neuroscience research, emphasizing the potential for advances in regenerative therapies and neural prostheses.

Duke University has received $8 million from the Duke Endowment to support the development of interdisciplinary PhD graduate education collaboratives to prepare doctoral students to tackle the most pressing societal problems of our time. Suzanne Barber, dean of the Graduate School and a professor of cell biology, will help implement the new programs.

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and complex class of genetic diseases caused by defects in a relatively large region of the genome.

Daichi Shonai, a PhD student at Duke University, hopes to identify early warning signs of Parkinson’s disease by investigating the early molecular changes within the nerve cells that stop functioning in this brain disorder.